Acupressure for Rheumatoid Arthritis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Michigan, Ann Arbor, MI
Rheumatoid Arthritis+2 More
Acupressure - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The goal of this pilot trial is to better understand if acupressure is feasible and tolerable to people with rheumatoid arthritis.

Eligible Conditions

  • Rheumatoid Arthritis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Rheumatoid Arthritis

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: Baseline to Day 42

Baseline to Day 42
Change in Fibromyalgia Survey Questionnaire
Change in the Patient-Reported Outcomes Measurement Information System Adult Profile (PROMIS-29 +2)
Day 42 (during acupressure)
Acceptability of self-performed acupressure in patients with RA assessed by Acupressure Tolerability Scale at day 42
Day 42
Feasibility of self-performed acupressure in patients with RA assessed by the number of sessions completed

Trial Safety

Safety Progress

1 of 3

Other trials for Rheumatoid Arthritis

Trial Design

1 Treatment Group

Acupressure
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Acupressure · No Placebo Group · N/A

Acupressure
Device
Experimental Group · 1 Intervention: Acupressure · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acupressure
2016
N/A
~1300

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to day 42
Closest Location: University of Michigan · Ann Arbor, MI
Photo of university of michigan comprehensive cancer center 1Photo of university of michigan comprehensive cancer center 2Photo of university of michigan comprehensive cancer center 3
2022First Recorded Clinical Trial
3 TrialsResearching Rheumatoid Arthritis
1005 CompletedClinical Trials

Who is running the clinical trial?

University of MichiganLead Sponsor
1,597 Previous Clinical Trials
6,329,027 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
163 Patients Enrolled for Rheumatoid Arthritis
Anne Murphy, MDPrincipal InvestigatorUniversity of Michigan

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.